Drug Research

The market for organs-on-chips (OOCs), the cell culture chips that imitate the activities, mechanisms and responses of organs, will be worth $284 millionby 2021, according to research from The Business Research Company in its report Organ-On-Chip (OOC) Global Market...

Beactica AB, the Swedish drug discovery company announced a new research collaboration with Uppsala University and the Drug Discovery and Development Platform at SciLifeLab to study the effects on brain cancer stem cells of specific small molecules under development...

InMed Pharmaceuticals, Inc. , a biopharmaceutical company specializing in the research and development of novel, cannabinoid-based drug therapies announced the filing of a provisional patent application in the United States.  INM-085 as a cannabinoid-based topical therapy...

Aptar Pharma and Kali Care have announced that they entered into a partnership in order to address the challenge of monitoring adherence in ophthalmic clinical trials. The combination of Aptar Pharma’s ophthalmic device expertise, and Kali Care’s ground-breaking...

The QCS EV 100 litre top loading autoclave is among the most space-efficient sterilisers available and will appeal to lab managers for their superior loading capability. They easily accommodate the tallest flasks, fermentors, and bioreactors, but...

At the discovery and early stages of drug development, the aim is to evaluate the pharmacology, pharmacokinetics and toxicology of a compound using a simple liquid formulation. During this process, drugs must dissolve at a concentration high enough to allow...

Bristol-Myers Squibb Company announced data from a Phase 2 study of BMS-986036, an investigational pegylated analogue of human fibroblast growth factor 21 (FGF21), a key regulator of metabolism, in patients with biopsy-confirmed nonalcoholic steatohepatitis (NASH) (F1-F3). ...